Related Experiment Video
Updated: Mar 13, 2026
06:08
Quantification of Hypopigmentation Activity In Vitro
Published on: March 6, 2019
12.1K
Kojic Acid Peptide: A New Compound with Anti-Tyrosinase Potential
Birendra Kumar Singh1, Seok Hoon Park2, Hyang-Bok Lee1
1Department of Biological Engineering, Inha University, Incheon, Korea.
Annals of Dermatology
|October 18, 2016
Summary
New kojic acid peptides show promise as stable, non-toxic antimelanogenic agents. These peptides effectively inhibit tyrosinase activity and melanin production in melanoma cells, addressing kojic acid
Area of Science:
- Biochemistry
- Dermatology
- Cosmetic Science
Background:
- Kojic acid, a long-standing cosmetic ingredient for antimelanogenic effects, suffers from cytotoxicity and storage instability.
- These limitations necessitated the development of novel kojic acid derivatives.
Purpose of the Study:
- To synthesize and evaluate five novel kojic acid peptides.
- To overcome the inherent limitations of kojic acid.
Main Methods:
- Peptide synthesis and purification using high-performance liquid chromatography (HPLC) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS).
- Comparative analysis of tyrosinase activity between kojic acid and its peptide derivatives.
- Assessment of melanin content and cytotoxicity in B16F10 mouse melanoma cells.
Main Results:
- Kojic acid peptides demonstrated enhanced tyrosinase inhibitory activity compared to kojic acid.
- The synthesized peptides were found to be stable.
- Melanin content and cytotoxicity assays confirmed the efficacy and safety profile.
Conclusions:
- The novel kojic acid peptides are stable, potent tyrosinase inhibitors, and effectively reduce melanin content in melanoma cells without toxicity.
- These findings suggest significant potential for kojic acid peptides as next-generation antimelanogenic agents.
- Further research is warranted to fully establish their therapeutic and cosmetic applications.
